Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2017 Apr 4.
Published in final edited form as: Angew Chem Int Ed Engl. 2016 Mar 8;55(15):4763–4766. doi: 10.1002/anie.201600007

Asymmetric Synthesis of Axinellamines A and B

Zhiqiang Ma 1, Xiao Wang 1, Yuyong Ma 1, Chuo Chen 1,*
PMCID: PMC4836294  NIHMSID: NIHMS777256  PMID: 27037993

Abstract

Axinellamines A and B are broad-spectrum anti-bacterial pyrrole–imidazole alkaloids that have a complex polycyclic skeleton. A new asymmetric synthesis of these marine sponge metabolites is described herein, featuring an oxidative rearrangement and an anchimeric chlorination reaction.

Keywords: alkaloids, anchimeric assistance, axinellamines, natural products, total synthesis


Axinellamines (1) are members of a family of dimeric pyrrole–imidazole natural products that have attracted the attention of synthetic chemists for decades (Figure 1).[1] Initially isolated by Quinn et al.,[2] these marine alkaloids have a densely functionalized polycyclic structure highly rich in nitrogen and halogen atoms (C:N:X ≈ 4:2:1). Recently, Romesberg, Baran, and co-workers have found that 1a and 1b display promising activity against both Gram-positive and Gram-negative bacteria and 1a causes membrane destabilization in Escherichia coli.[3] Among several labs that study the synthesis of dimeric pyrrole–imidazole alkaloids 13,[316] Carreira et al. reported the first synthetic strategy directed towards 1[6] using a Diels–Alder reaction to establish its fully functionalized cyclopentyl core. Romo and co-workers subsequently disclosed an oxidative ring-contraction approach that was inspired by Scheuer’s biosynthetic hypothesis.[7,17] This skeletal rearrangement reaction has also been studied by Lovely et al.[8] The total synthesis of 1 was accomplished by the Baran group by using two different approaches.[35] The group first used an intramolecular aldol reaction to construct the cyclopentyl core of 1. This approach has enabled the asymmetric synthesis of not only 1,[4] but also massadines (2),[9] and palau’amine (3).[10] They subsequently developed a second-generation synthesis wherein the cyclopentyl core of 1 was assembled by a Pauson–Khand reaction.[3,5] This new approach has further allowed for the gramscale synthesis of 1. Meanwhile, Harran et al. have achieved the synthesis of 13-dechloro-6′,6″-didebromo-1 using an oxidative enolate coupling strategy,[11] and Namba, Tanino, and co-workers have reported the synthesis of 3.[12] We report herein a new asymmetric synthesis of 1.

Figure 1.

Figure 1

The structures of axinellamines (1), massadines (2), palau’amine (3), and protected ent-10′-hydroxydibromoageliferin (4).

Our general synthetic strategy for 13 resembles the approach of Romo et al. with a “Scheuer rearrangement” serving as the key transformation.[7,8,1417] Previously, we used the 10′-hydroxy group of 4 (protected ent-10′-hydroxydibromoageliferin) to set up the desired spiro-configuration of 2a through directed oxidation.[15] However, we were not able to convert this hydroxy directing group into a chloride at a late stage to achieve the synthesis of 1. We thus switched to developing a new route with an early introduction of the chloride despite its reported hydrolytic instability.[5,9,10,18,19]

Using azidoimidazole 5 (prepared in 10 steps from (S)-Garner’s aldehyde)[14,15] as the common intermediate for 1 and 2a, the synthesis of axinellamines (1) commenced with the selective reduction of the azido group on the imidazole ring and epimerization of the C12 stereocenter (Scheme 1). We found that the imidazoyl azide of 5 could be reduced immediately upon addition of triphenylphosphine at room temperature, whereas the alkyl azide would not react until warming the reaction mixture to 40°C. The resulting imidazoyl iminophosphorane is hydrolytically stable over a range of pH values, making it a good protected form of aminoimidazole.[14c] Epimerization of the C12 stereocenter was achieved after converting the acetonide group into the bulky silyl protecting group TBS (tert-butyldimethylsilyl). In contrast to 5 that strongly favors a cis-11,12-configuration,[14b] 12-epi-6 slowly epimerized under basic conditions to provide a 3:2 mixture of 6 and 12-epi-6 (82% combined yield over four steps).

Scheme 1.

Scheme 1

Synthesis of axinellamines. Reaction conditions: 56: a) PPh3, THF, 23°C, 2 h; b) HCl, EtOAc, 23°C, 2 h; c) TBSCl, imidazole, CH2Cl2, 23°C, 2 h; d) LiOH, THF/H2O 4/1 v/v, 23°C, 48 h (49% 6 and 33% 12-epi-6 over 4 steps). 67: e) LiAlH4, THF, 0°C, 1 h. 78: f) Ti(OiPr)4, TBHP, 4 Å molecular sieves, CH2Cl2/decane 190/1 v/v, −20→0°C, 2 h. 810: g) MsCl, pyridine, THF, 0→23°C, 1 h; h) nBu4NCl, 4 Å molecular sieves, pyridine, 70°C, 12 h (72% over 4 steps (from 610)). 1012: i) Zn, NH4Cl, MeOH/H2O 10/1 v/v, 23°C, 3 h; j) TFA, CH2Cl2, 23°C, 80 min; k) 4,5-dibromo-2-(trichloroacetyl)pyrrole, NEt3, DMF, 50°C, 12 h; l) TBAF, THF, 23°C, 48 h (30% over 4 steps). 1213: m) IBX, DMSO, 40°C, 15 h; n) TFA, H2O, CH2Cl2, 23°C, 2 h; o) NH2CN, MeOH, H2O, 50°C, 2 h; p) TFA, CH2Cl2, 23°C, 2 h (42% over 4 steps). 131b: q) BCl3, CH2Cl2, 0°C, 15 min (64%); r) NH4OH, H2, CH3CN, 0°C, 2 h (for chloromethyl iminohydantoin only); then HCl, THF, 45°C, 12 h (81%); s) AD-mix-α, MeSO2NH2, tBuOH-H2O, 0°C, 50 min (55%, d.r.= 2:1–3:1); t) SmI2, H2O, THF, 23°C, 2 h, (67%); u) N-bromosuccinimide (NBS), CH3CN, 0°C, 24 h (53%). 1316: v) SmI2, H2O, THF, −40→23°C, 1 h (< 47%). 1617: w) AD-mix-α, MeSO2NH2, tBuOH-H2O, 0°C, 20 min (35%, d.r.>10:1). BOM=benzyloxymethyl; Boc= tert-butoxycarbonyl; IBX= 2-iodooxybenzoic acid.

To establish the central cyclopentyl ring of 1, the ketone group of 6 was first reduced to create a directing group for the Scheuer rearrangement. Substituting the previously used lithium triethylborohydride[15] with lithium aluminum hydride eliminated issues associated with the formation of a borane complex of 7. Treatment of 7 with titanium tetraisopropoxide and tert-butyl hydroperoxide (TBHP) induced the Scheuer rearrangement to afford axinellamine core 8 with the desired spiro-configuration.[15]

We next set out to develop a method for introducing the C13-positioned chlorine atom. Romo et al. reported that stereoretentive displacement of the C13 chloride could be achieved by anchimeric assistance of the neighboring nitrogen atom and proposed that massadine (2a) was produced by hydrolysis of the then elusive massadine chloride (2b).[7d] Meanwhile, Köck, Baran, and co-workers successfully isolated 2b from pyrrole–imidazole alkaloid-producing sponges and demonstrated that 2b could be hydrolyzed to 2a.[18] The Köck group has further delineated the antiparallel alignment of the leaving group with the neighboring nitrogen atom as a requirement for facile displacement. However, Capon et al. reported that 14-O-sulfate massadine (2c) does not hydrolyze to 2a over a range of pH values.[19] Thus, proper alignment is not sufficient for anchimeric displacement and there is no direct relationship between the hydrolysis rate and the pKa value of the leaving group.[20]

We envisioned that chlorination of 8 would be a viable approach for the synthesis of 1 according to the principle of microscopic reversibility. Indeed, Namba, Tanino, et al. have recently succeeded in using this strategy to synthesize 3.[12] We found that reaction of 8 with mesyl chloride (MsCl) gave a mesylate that smoothly reacted with tetrabutylammonium chloride to give 10 through phosphonium aziridine 9 (72% yield over four steps).

To install the dibromopyrrole and aminoimidazole groups, we reduced the azido group of 10 and selectively removed the less hindered carbamate protecting group using trifluoroacetic acid (TFA) to generate diamine 11. The dibromopyr-role groups were then introduced and the silyl protecting group removed using tetrabutylammonium fluoride (TBAF) to provide alcohol 12 (30% yield over four steps). The construction of the second aminoimidazole group started with oxidation of the hydroxy group and removal of the carbamate group to give a metastable amino aldehyde that presumably existed as a hydrate according to LCMS analyses. Subsequent condensation with cyanamide[9,10,21] afforded the desired aminoimidazole 13 (42% yield over four steps). The cyclization step could be accelerated by treating the initial condensation product with trifluoroacetic acid. In contrast to Baran’s system,[5] our iminohydantoin-bearing chlorides are relatively stable. Hydrolysis only occurred partially with 13 when carrying out the condensation at elevated temperatures and with extended reaction times. Additionally, there is no epimerization of the C14-spiro-quaternary center, as was observed by Harran and co-workers.[22]

To complete the synthesis of 1, we first adjusted the C1-oxidation state of 13. During the synthesis of 2a, we found that the C13-hydroxy analogue of 13 could be reduced easily under a variety of conditions.[15] However, similar treatment of 13 with calcium borohydride or lithium aluminum hydride resulted in complete decomposition. Attempts to reduce 13 with sodium borohydride in methanol[13a] at elevated temperatures led to the formation of methoxide 14. We suspected that, in the synthesis of 2a, the C13-hydroxy group formed a complex with the reducing agent and facilitated C1 reduction. Therefore, a more nucleophilic hydride is needed to reduce the iminohydantoin group of 13. Indeed, lithium triethylborohydride effectively reduced the C1-carbonyl group of 13, however, with C13 dechlorination to give 15.

Eventually, we found that C1 reduction could be accomplished without dechlorination by treating 13 with samarium diiodide[11] to give aminal 16 with concomitant 6′,6″-di-debromination and hydrolysis of the iminophosphorane group. Subsequent oxidation of the aminoimidazole group with AD-mix-α established the N4–C5 linkage and provided the complete axinellamine B skeleton (d.r. > 10:1). Notably, the oxidative cyclization induced by dioxirane[4] or oxaziridine[11] favors the formation of the alternative axinellamine A stereochemistry.

Although the synthesis of 1b was achieved by bromination and deprotection of 17 initially, we were not able to obtain a consistent yield of 16 as a result of multiple competing reactions. We thus altered the reaction sequence to establish a robust synthetic route. Treatment of 13 with boron trichloride gave a mixture of hydroxymethyl and chloromethyl iminohydantoins that could be hydrolyzed together with the iminophosphorane group (52% yield over two steps). The following oxidative cyclization provided the axinellamine skeletons (55% yield), however, with diminished stereochemical preference (d.r. = 2:1–3:1). Both AD-mix-α and AD-mix-β gave the same diastereoselectivity. Subsequent C1 reduction proceeded smoothly (67% yield) to give 1b from the major diastereomer after reinstallation of the 6′ and 6″-bromine atoms (53% yield). Reduction of the minor diastereomer followed by bromination provided 1a. The CD spectra of our synthetic 1 match those of the natural products.[4c,19]

In summary, the asymmetric synthesis of axinellamines A and B (1) was achieved in 31 steps from (S)-Garner’s aldehyde (0.01% and 0.04% overall yield, respectively). The core structure of 1 was established by directed Scheuer rearrangement and the hydroxy directing group was converted into chloride by anchimeric displacement. Although literature reports suggest that the reverse reaction, namely, the hydrolysis of chloride, is highly favored, we found that the hydrolytic stability of the chloride could be improved by modulating the electronic properties of the adjacent spiro-heterocycle. Application of this approach to the synthesis of other chlorine-containing pyrrole–imidazole dimers is underway.

Supplementary Material

Supporting Information

Acknowledgements

We thank the NIH (NIGMS R01-GM079554), the Welch Foundation (I-1868), and UT Southwestern for financial support.

Footnotes

Dedicated to Professor Stuart L. Schreiber on the occasion of his 60th birthday

Supporting information and the ORCID identification number(s) for the author(s) of this article can be found under http://dx.doi.org/10.1002/anie.201600007.

References

  • [1].a) Ma Y, De S, Chen C. Tetrahedron. 2014;70:1145–1173. doi: 10.1016/j.tet.2014.11.056. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Wang X, Ma Z, Wang X, De S, Ma Y, Chen C. Chem. Commun. 2014;50:8628–8639. doi: 10.1039/c4cc02290d. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Al-Mourabit A, Zancanella MA, Tilvi S, Romo D. Nat. Prod. Rep. 2011;28:1229–1260. doi: 10.1039/c0np00013b. [DOI] [PMC free article] [PubMed] [Google Scholar]; d) Heasley B. Eur. J. Org. Chem. 2009:1477–1489. [Google Scholar]; e) Forte B, Malgesini B, Piutti C, Quartieri F, Scolaro A, Papeo G. Mar. Drugs. 2009;7:705–753. doi: 10.3390/md7040705. [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Arndt H-D, Riedrich M. Angew. Chem. Int. Ed. 2008;47:4785–4788. doi: 10.1002/anie.200801793. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008;120:4864–4867. [Google Scholar]; g) Weinreb SM. Nat. Prod. Rep. 2007;24:931–948. doi: 10.1039/b700206h. [DOI] [PubMed] [Google Scholar]; h) Köck M, Grube A, Seiple IB, Baran PS. Angew. Chem. Int. Ed. 2007;46:6586–6594. doi: 10.1002/anie.200701798. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2007;119:6706–6714. [Google Scholar]; i) Du H, He Y, Sivappa R, Lovely CJ. Synlett. 2006:965–992. [Google Scholar]; j) Jacquot DEN, Lindel T. Curr. Org. Chem. 2005;9:1551–1565. [Google Scholar]; k) Hoffmann H, Lindel T. Synthesis. 2003:1753–1783. [Google Scholar]
  • [2].a) Urban S, de Almeida Leone P, Carroll AR, Fechner GA, Smith J, Hooper JNA, Quinn RJ. J. Org. Chem. 1999;64:731–735. doi: 10.1021/jo981034g. [DOI] [PubMed] [Google Scholar]; b) Yasuda T, Araki A, Kubota T, Ito J, Mikami Y, Fromont J, Kobayashi JI. J. Nat. Prod. 2009;72:488–491. doi: 10.1021/np800645q. [DOI] [PubMed] [Google Scholar]
  • [3].Rodriguez RA, Steed DB, Kawamata Y, Su S, Smith PA, Steed TC, Romesberg FE, Baran PS. J. Am. Chem. Soc. 2014;136:15403–15413. doi: 10.1021/ja508632y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [4].a) Yamaguchi J, Seiple IB, Young IS, O’Malley DP, Maue M, Baran PS. Angew. Chem. Int. Ed. 2008;47:3578–3580. doi: 10.1002/anie.200705913. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008;120:3634–3636. [Google Scholar]; b) OÏMalley DP, Yamaguchi J, Young IS, Seiple IB, Baran PS. Angew. Chem. Int. Ed. 2008;47:3581–3583. doi: 10.1002/anie.200801138. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008;120:3637–3639. [Google Scholar]; c) Seiple IB, Su S, Young IS, Nakamura A, Yamaguchi J, Jørgensen L, Rodriguez RA, O’Malley DP, Gaich T, Köck M, Baran PS. J. Am. Chem. Soc. 2011;133:14710–14726. doi: 10.1021/ja2047232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [5].Su S, Rodriguez RA, Baran PS. J. Am. Chem. Soc. 2011;133:13922–13925. doi: 10.1021/ja206191g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [6].a) Starr JT, Koch G, Carreira EM. J. Am. Chem. Soc. 2000;122:8793–8794. [Google Scholar]; b) Breder A, Chinigo GM, Waltman AW, Carreira EM. Angew. Chem. Int. Ed. 2008;47:8514–8517. doi: 10.1002/anie.200803284. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008;120:8642–8645. doi: 10.1002/anie.200803529. [DOI] [PubMed] [Google Scholar]; c) Chinigo GM, Breder A, Carreira EM. Org. Lett. 2011;13:78–81. doi: 10.1021/ol102577q. [DOI] [PubMed] [Google Scholar]; d) Breder A, Chinigo GM, Waltman AW, Carreira EM. Chem. Eur. J. 2011;17:12405–12416. doi: 10.1002/chem.201101862. [DOI] [PubMed] [Google Scholar]
  • [7].a) Dilley AS, Romo D. Org. Lett. 2001;3:1535–1538. doi: 10.1021/ol015864j. [DOI] [PubMed] [Google Scholar]; b) Dransfield PJ, Wang S, Dilley A, Romo D. Org. Lett. 2005;7:1679–1682. doi: 10.1021/ol0473602. [DOI] [PubMed] [Google Scholar]; c) Dransfield PJ, Dilley AS, Wang S, Romo D. Tetrahedron. 2006;62:5223–5247. [Google Scholar]; d) Wang S, Dilley AS, Poullennec KG, Romo D. Tetrahedron. 2006;62:7155–7161. [Google Scholar]; e) Zancanella MA, Romo D. Org. Lett. 2008;10:3685–3688. doi: 10.1021/ol801289b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].a) Lovely CJ, Du H, He Y, Dias HVR. Org. Lett. 2004;6:735–738. doi: 10.1021/ol036403w. [DOI] [PubMed] [Google Scholar]; b) Sivappa R, Hernandez NM, He Y, Lovely CJ. Org. Lett. 2007;9:3861–3864. doi: 10.1021/ol0711568. [DOI] [PubMed] [Google Scholar]
  • [9].Su S, Seiple IB, Young IS, Baran PS. J. Am. Chem. Soc. 2008;130:16490–16491. doi: 10.1021/ja8074852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Seiple IB, Su S, Young IS, Lewis CA, Yamaguchi J, Baran PS. Angew. Chem. Int. Ed. 2010;49:1095–1098. doi: 10.1002/anie.200907112. [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2010;122:1113–1116. [Google Scholar]
  • [11].Ding H, Roberts AG, Harran PG. Angew. Chem. Int. Ed. 2012;51:4340–4343. doi: 10.1002/anie.201200205. [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2012;124:4416–4419. [Google Scholar]
  • [12].Namba K, Takeuchi K, Kaihara Y, Oda M, Nakayama A, Nakayama A, Yoshida M, Tanino K. Nat. Commun. 2015;6:8731. doi: 10.1038/ncomms9731. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].a) Lanman BA, Overman LE, Paulini R, White NS. J. Am. Chem. Soc. 2007;129:12896–12900. doi: 10.1021/ja074939x. [DOI] [PMC free article] [PubMed] [Google Scholar]; b) Koenig SG, Miller SM, Leonard KA, Löwe RS, Chen BC, Austin DJ. Org. Lett. 2003;5:2203–2206. doi: 10.1021/ol0344063. [DOI] [PubMed] [Google Scholar]; c) Hudon J, Cernak TA, Ashenhurst JA, Gleason JL. Angew. Chem. Int. Ed. 2008;47:8885–8888. doi: 10.1002/anie.200803344. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2008;120:9017–9020. [Google Scholar]; d) Bultman MS, Ma J, Gin DY. Angew. Chem. Int. Ed. 2008;47:6821–6824. doi: 10.1002/anie.200801969. [DOI] [PMC free article] [PubMed] [Google Scholar]; Angew. Chem. 2008;120:6927–6930. [Google Scholar]; e) Namba K, Inai M, Sundermeier U, Greshock TJ, Williams RM. Tetrahedron Lett. 2010;51:6557–6559. doi: 10.1016/j.tetlet.2010.10.037. [DOI] [PMC free article] [PubMed] [Google Scholar]; f) Feldman KS, Nuriye AY, Li J. J. Org. Chem. 2011;76:5042–5060. doi: 10.1021/jo200740b. [DOI] [PubMed] [Google Scholar]; g) Fukahori Y, Takayama Y, Imaoka T, Iwamoto O, Nagasawa K. Chem. Asian J. 2012;7:244–250. doi: 10.1002/asia.201200820. [DOI] [PubMed] [Google Scholar]; h) Sun C, Lee H, Lee D. Org. Lett. 2015;17:5348–5351. doi: 10.1021/acs.orglett.5b02709. [DOI] [PubMed] [Google Scholar]
  • [14].a) Tan X, Chen C. Angew. Chem. Int. Ed. 2006;45:4345–4348. doi: 10.1002/anie.200601208. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2006;118:4451–4454. [Google Scholar]; b) Wang X, Ma Z, Lu J, Tan X, Chen C. J. Am. Chem. Soc. 2011;133:15350–15353. doi: 10.1021/ja207386q. [DOI] [PMC free article] [PubMed] [Google Scholar]; c) Wang X, Wang X-L, Tan X, Lu J, Cormier KW, Ma Z, Chen C. J. Am. Chem. Soc. 2012;134:18834–18842. doi: 10.1021/ja309172t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [15].Ma Z, Wang X-L, Wang X, Rodriguez RA, Moore CE, Gao S, Tan X, Ma Y, Rheingold AL, Baran PS, Chen C. Science. 2014;346:219–224. doi: 10.1126/science.1255677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].O’Malley DP, Li K, Maue M, Zografos AL, Baran PS. J. Am. Chem. Soc. 2007;129:4762–4775. doi: 10.1021/ja069035a. [DOI] [PubMed] [Google Scholar]
  • [17].a) Kinnel RB, Gehrken H-P, Swali R, Skoropowski G, Scheuer PJ. J. Org. Chem. 1998;63:3281–3286. [Google Scholar]; b) Ma Z, Lu J, Wang X, Chen C. Chem. Commun. 2011;47:427–429. doi: 10.1039/c0cc02214d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].a) Grube A, Immel S, Baran PS, Köck M. Angew. Chem. Int. Ed. 2007;46:6721–6724. doi: 10.1002/anie.200701935. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2007;119:6842–6845. [Google Scholar]; b) Grube A, Immel S, Baran PS, Köck M. Angew. Chem. Int. Ed. 2007;46:8107–8107. doi: 10.1002/anie.200701935. [DOI] [PubMed] [Google Scholar]; Angew. Chem. 2007;119:8253–8253. [Google Scholar]
  • [19].Zhang H, Khalil Z, Conte MM, Plisson F, Capon RJ. Tetrahedron Lett. 2012;53:3784–3787. [Google Scholar]
  • [20].a) Stirling CJM. Acc. Chem. Res. 1979;12:198–203. [Google Scholar]; b) Boyd DB. J. Org. Chem. 1985;50:885–886. [Google Scholar]; c) Pearson RG. J. Org. Chem. 1987;52:2131–2136. [Google Scholar]; d) Anderson JSM, Liu Y, Thomson JW, Ayers PW. J. Mol. Struct. Theochem. 2010;943:168–177. [Google Scholar]
  • [21].Foley LH, Büchi G. J. Am. Chem. Soc. 1982;104:1776–1777. [Google Scholar]
  • [22].Ding H, Roberts AG, Harran PG. Chem. Sci. 2012;3:303–306. doi: 10.1039/C2SC21651E. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES